Literature DB >> 24553098

The role of noncoding regions of classical swine fever virus C-strain in its adaptation to the rabbit.

Chao Li1, Yongfeng Li1, Liang Shen1, Junhua Huang1, Yuan Sun1, Yuzi Luo1, Bibo Zhao1, Chunhua Wang1, Jin Yuan1, Hua-Ji Qiu2.   

Abstract

Classical swine fever (CSF) is a devastating disease of swine caused by classical swine fever virus (CSFV). C-strain, a modified live vaccine against CSF, was developed through hundreds of passages of a highly virulent CSFV in the rabbit in China in the mid-1950s. To identify the role of noncoding regions (NCRs) of C-strain in its adaptation to the rabbit, we generated and evaluated a series of chimeric viruses derived from C-strain and the highly virulent Shimen strain. The results demonstrated that the NCRs of the C-strain were essential for its fever induction in rabbits and the coding region but not NCRs was necessary for its replication in the spleen of rabbits.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptation to the rabbit; C-strain; Classical swine fever virus; Fever induction; Noncoding regions; Replication in the spleen

Mesh:

Substances:

Year:  2014        PMID: 24553098     DOI: 10.1016/j.virusres.2014.02.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.

Authors:  Yongfeng Li; Mengqi Yuan; Yuying Han; Libao Xie; Yuteng Ma; Su Li; Yuan Sun; Yuzi Luo; Weike Li; Hua-Ji Qiu
Journal:  J Virol       Date:  2021-11-03       Impact factor: 5.103

2.  Proline to Threonine Mutation at Position 162 of NS5B of Classical Swine Fever Virus Vaccine C Strain Promoted Genome Replication and Infectious Virus Production by Facilitating Initiation of RNA Synthesis.

Authors:  Huining Pang; Ling Li; Hongru Liu; Zishu Pan
Journal:  Viruses       Date:  2021-08-02       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.